Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer

Autor: Guardiola, E., Peyrade, F., Chaigneau, L., Cupissol, D., Tchiknavorian, X., Bompas, E., Madroszyk, A., Ronchin, P., Schneider, M., Bleuze, J.P., Blay, J.Y., Pivot, X.
Zdroj: In European Journal of Cancer 2004 40(14):2071-2076
Databáze: ScienceDirect